Sunrest Lifescience Limited
- IPO Date07 Nov, 2023 to 09 Nov, 2023
- Listing Date20 Nov, 2023
- Face Value₹10 per share
- Issue Price₹84 to ₹84 per share
- Lot Size1600 Shares
- Minimum Investment₹1,34,400
- Listing AtNSE SME
- Total Issue Size12,91,200 Shares
(aggregating up to ₹10.85 Cr) - Fresh Issue12,91,200 Shares
(aggregating up to ₹10.85 Cr)
- Offer for Sale-
- Issue TypeFixed Price Issue IPO
- Share holding pre issue30,00,000
- Shareholding post issue42,91,200
IPO Dates
Closing Date
09 Nov, 2023
Initiation of Refunds
17 Nov, 2023
Listing Date
20 Nov, 2023
07 Nov, 2023
Opening Date
15 Nov, 2023
Basis of Allotment
17 Nov, 2023
Credit of Shares
Sunrest Lifescience Limited Lot Size
Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,34,400 |
| HNI (Min) | 2 | 3200 | ₹2,68,800 |
| Retail (Max) | 1 | 1600 | ₹1,34,400 |
Sunrest Lifescience Limited Promoter Holding
The promoters of the company are Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakkar.
| Pre Issue Share Holding | Post Issue Share Holding |
|---|---|
| 100% | 69.91% |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 53% |
| ROCE | 98% |
| RoNW | 65.59% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 12.33 | 6.81 |
| P/E (x) | 12.33 | 6.81 |
Sunrest Lifescience Limited COMPANY INFORMATION
Sunrest Lifescience IPO is a fixed price issue of Rs 10.85 crores. The issue is entirely a fresh issue of 12.91 lakh shares. Sunrest Lifescience IPO opens for subscription on November 7, 2023 and closes on November 9, 2023. The allotment for the Sunrest Lifescience IPO is expected to be finalized on Wednesday, November 15, 2023. Sunrest Lifescience IPO will list on NSE SME with tentative listing date fixed as Monday, November 20, 2023. Sunrest Lifescience IPO price is ₹84 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹134,400. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹268,800. Mark Corporate Advisors Private Limited is the book running lead manager of the Sunrest Lifescience IPO, while Skyline Financial Services Private Ltd is the registrar for the issue. The market maker for Sunrest Lifescience IPO is Svcm Securities. Refer to Sunrest Lifescience IPO RHP for detailed information.
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.
The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.
The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.
Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.
With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
FAQs About Sunrest Lifescience Limited
Sunrest Lifescience Limited will open on 07 Nov, 2023 and close on 09 Nov, 2023. Investors must apply within this period to participate.
The Sunrest Lifescience Limited price band is set between ₹84.00 and ₹84.00 per share. The minimum lot size is 1600, requiring an investment of at least ₹134400.00.
The Sunrest Lifescience Limited shares are expected to be listed on 20 Nov, 2023, subject to regulatory approvals and final allotment.
You can track your Sunrest Lifescience Limited application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID
The Sunrest Lifescience Limited will be listed on major stock exchanges such as NSE and BSE, where you can trade shares once they are listed.